4.2 Letter

Is it time to modify the Japanese Uterine Cervical Cancer Guidelines to recommend a higher dose for radio-resistant tumors?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biology

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

Naoya Murakami et al.

Summary: The study suggested the possibility of de-escalation for cervical cancer, similar to HPV-related oropharyngeal cancer. However, the classification was based on tumor shrinkage after half of the treatment, while another article found adverse factors that could be obtained prior to treatment, allowing for earlier patient classification.

JOURNAL OF RADIATION RESEARCH (2022)

Article Oncology

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies

Naoya Murakami et al.

Summary: This study investigated the efficacy and side effects of salvage re-irradiation using image-guided high-dose-rate brachytherapy (IG-HDR-BT) in patients with gynecologic malignancies who had a history of pelvic irradiation. The results showed that re-irradiation with IG-HDR-BT could be considered in patients with recurrent disease, especially those with small tumor size and no history of bevacizumab usage.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2022)

Article Biology

An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma

Naoya Murakami et al.

Summary: This study compared the clinical outcomes between intracavitary brachytherapy (ICBT) and the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients. The results showed that, despite having more advanced disease, patients in the HBT group did not demonstrate superior outcomes in terms of local control, progression-free survival, or overall survival.

JOURNAL OF RADIATION RESEARCH (2022)

Article Biology

Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers

Naoya Murakami et al.

Summary: This article discusses the effectiveness and safety of intracavitary and interstitial brachytherapy (IC/IS) in treating large and irregularly shaped uterine cervical cancer patients. Compared to conventional intracavitary brachytherapy (ICBT), IC/IS is more invasive and thus has a slower implementation speed. The article aims to provide practical and comprehensive guidance for radiation oncologists and medical physicists who wish to start IC/IS, and to accelerate the nationwide utilization of IC/IS by sharing the Japanese approach to managing locally advanced uterine cervical cancer.

JOURNAL OF RADIATION RESEARCH (2022)

Article Biology

Now is it time to implement spacers in cervical cancer brachytherapy?

Naoya Murakami et al.

Summary: The international study EMBRACE-I showed excellent local control in cervical cancer but a high percentage of late radiation-related toxicities. Despite reported efficacy in cervical cancer, the implementation of hydrogel spacers has been slow. Rapid implementation of spacers in cervical cancer brachytherapy is needed to reduce toxicity and improve patients' quality of life.

JOURNAL OF RADIATION RESEARCH (2022)

Article Oncology

Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial

Naoya Murakami et al.

Summary: The feasibility and reproducibility of the hybrid of intracavitary and interstitial brachytherapy were demonstrated in a multi-center prospective clinical trial. High-risk clinical target volume >= 35 ml was associated with an increased risk of any grade of acute non-hematologic adverse events related to the hybrid of intracavitary and interstitial brachytherapy.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Why not de-intensification for uterine cervical cancer?

Naoya Murakami et al.

Summary: In the management of cervical cancer, low-risk patients can achieve favorable local control with de-escalated treatment intensity. Factors such as tumor reduction ratio, tumor size, and total treatment time can be used to identify these low-risk patients.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer

Yasuhiko Ebina et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Oncology

Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (

Takafumi Toita et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)